Serial macro-architectural alterations with levodopa in Parkinson′s disease: Polysomnography (PSG)-based analysis

Purpose: We studied the sleep macroarchitecture with polysomnography (PSG) in drug naïve patients with Parkinson′s disease (PD) and reassessed them following treatment with levodopa. Materials and Methods: This prospective hospital-based study included 15 patients with PD (age: 59 ± 11.2 years, dura...

Full description

Bibliographic Details
Main Authors: Sanju P Joy, Sanjib Sinha, Pramod Kumar Pal, Samhita Panda, M Philip, Arun B Taly
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Annals of Indian Academy of Neurology
Subjects:
Online Access:http://www.annalsofian.org/article.asp?issn=0972-2327;year=2015;volume=18;issue=3;spage=309;epage=313;aulast=Joy
_version_ 1818081315938893824
author Sanju P Joy
Sanjib Sinha
Pramod Kumar Pal
Samhita Panda
M Philip
Arun B Taly
author_facet Sanju P Joy
Sanjib Sinha
Pramod Kumar Pal
Samhita Panda
M Philip
Arun B Taly
author_sort Sanju P Joy
collection DOAJ
description Purpose: We studied the sleep macroarchitecture with polysomnography (PSG) in drug naïve patients with Parkinson′s disease (PD) and reassessed them following treatment with levodopa. Materials and Methods: This prospective hospital-based study included 15 patients with PD (age: 59 ± 11.2 years, duration of PD: 11.8 ± 12.3 months; and male: female (M:F) = 11:4). They were assessed for demography, phenotype, modified Hoehn and Yahr staging (H & Y); Schwab and England and Activities of Daily Living (S and E ADL) Scale; and Unified PDRating Scale (UPDRS). Sleep was assessed using Epworth Sleepiness Scale (ESS), Pittsburgh Sleep Quality Index (PSQI), and National Institute of Mental Health and Neurosciences (NIMHANS) comprehensive sleep disorder questionnaire. They underwent overnight PSG at baseline and after13.3 ± 5.7 months of levodopa (440 mg/day). Results: Patients with PD had responded to levodopa as indicated by the significant improvement in UPDRS motor score in ON state compared to OFF state. Nocturnal sleep quality indices did not vary significantly, but the excessive daytime somnolence improved (P = 0.04) with levodopa. Sleep efficiency (P = 0.65), latency to sleep onset (P = 0.19), latency to stage 1 (P = 0.12), and duration of stage 1 (P = 0.55) had increased. Duration of ′awake in bed′ (P = 0.24), slow wave sleep (P = 0.29), and rapid eye movement (REM) sleep (P = 0.24) decreased with treatment. Periodic leg movements (PLMs) had reduced (P = 0.68) and mean oxygen saturation during sleep improved (P = 0.002). Surprisingly, snore index (P < 0.03) during sleep had increased with levodopa. Conclusions: Sleep alterations in PD occur even in early stages due to the disease process. There was improvement in most of the parameters of sleep macroarchitecture with levodopa.
first_indexed 2024-12-10T19:04:16Z
format Article
id doaj.art-869c8535fe8b4271b2f8645058319ad2
institution Directory Open Access Journal
issn 0972-2327
1998-3549
language English
last_indexed 2024-12-10T19:04:16Z
publishDate 2015-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Annals of Indian Academy of Neurology
spelling doaj.art-869c8535fe8b4271b2f8645058319ad22022-12-22T01:36:55ZengWolters Kluwer Medknow PublicationsAnnals of Indian Academy of Neurology0972-23271998-35492015-01-0118330931310.4103/0972-2327.160102Serial macro-architectural alterations with levodopa in Parkinson′s disease: Polysomnography (PSG)-based analysisSanju P JoySanjib SinhaPramod Kumar PalSamhita PandaM PhilipArun B TalyPurpose: We studied the sleep macroarchitecture with polysomnography (PSG) in drug naïve patients with Parkinson′s disease (PD) and reassessed them following treatment with levodopa. Materials and Methods: This prospective hospital-based study included 15 patients with PD (age: 59 ± 11.2 years, duration of PD: 11.8 ± 12.3 months; and male: female (M:F) = 11:4). They were assessed for demography, phenotype, modified Hoehn and Yahr staging (H & Y); Schwab and England and Activities of Daily Living (S and E ADL) Scale; and Unified PDRating Scale (UPDRS). Sleep was assessed using Epworth Sleepiness Scale (ESS), Pittsburgh Sleep Quality Index (PSQI), and National Institute of Mental Health and Neurosciences (NIMHANS) comprehensive sleep disorder questionnaire. They underwent overnight PSG at baseline and after13.3 ± 5.7 months of levodopa (440 mg/day). Results: Patients with PD had responded to levodopa as indicated by the significant improvement in UPDRS motor score in ON state compared to OFF state. Nocturnal sleep quality indices did not vary significantly, but the excessive daytime somnolence improved (P = 0.04) with levodopa. Sleep efficiency (P = 0.65), latency to sleep onset (P = 0.19), latency to stage 1 (P = 0.12), and duration of stage 1 (P = 0.55) had increased. Duration of ′awake in bed′ (P = 0.24), slow wave sleep (P = 0.29), and rapid eye movement (REM) sleep (P = 0.24) decreased with treatment. Periodic leg movements (PLMs) had reduced (P = 0.68) and mean oxygen saturation during sleep improved (P = 0.002). Surprisingly, snore index (P < 0.03) during sleep had increased with levodopa. Conclusions: Sleep alterations in PD occur even in early stages due to the disease process. There was improvement in most of the parameters of sleep macroarchitecture with levodopa.http://www.annalsofian.org/article.asp?issn=0972-2327;year=2015;volume=18;issue=3;spage=309;epage=313;aulast=JoyLevodopaParkinson′s diseasepolysomnographysleep
spellingShingle Sanju P Joy
Sanjib Sinha
Pramod Kumar Pal
Samhita Panda
M Philip
Arun B Taly
Serial macro-architectural alterations with levodopa in Parkinson′s disease: Polysomnography (PSG)-based analysis
Annals of Indian Academy of Neurology
Levodopa
Parkinson′s disease
polysomnography
sleep
title Serial macro-architectural alterations with levodopa in Parkinson′s disease: Polysomnography (PSG)-based analysis
title_full Serial macro-architectural alterations with levodopa in Parkinson′s disease: Polysomnography (PSG)-based analysis
title_fullStr Serial macro-architectural alterations with levodopa in Parkinson′s disease: Polysomnography (PSG)-based analysis
title_full_unstemmed Serial macro-architectural alterations with levodopa in Parkinson′s disease: Polysomnography (PSG)-based analysis
title_short Serial macro-architectural alterations with levodopa in Parkinson′s disease: Polysomnography (PSG)-based analysis
title_sort serial macro architectural alterations with levodopa in parkinson s disease polysomnography psg based analysis
topic Levodopa
Parkinson′s disease
polysomnography
sleep
url http://www.annalsofian.org/article.asp?issn=0972-2327;year=2015;volume=18;issue=3;spage=309;epage=313;aulast=Joy
work_keys_str_mv AT sanjupjoy serialmacroarchitecturalalterationswithlevodopainparkinsonsdiseasepolysomnographypsgbasedanalysis
AT sanjibsinha serialmacroarchitecturalalterationswithlevodopainparkinsonsdiseasepolysomnographypsgbasedanalysis
AT pramodkumarpal serialmacroarchitecturalalterationswithlevodopainparkinsonsdiseasepolysomnographypsgbasedanalysis
AT samhitapanda serialmacroarchitecturalalterationswithlevodopainparkinsonsdiseasepolysomnographypsgbasedanalysis
AT mphilip serialmacroarchitecturalalterationswithlevodopainparkinsonsdiseasepolysomnographypsgbasedanalysis
AT arunbtaly serialmacroarchitecturalalterationswithlevodopainparkinsonsdiseasepolysomnographypsgbasedanalysis